AKT1 and melanoma: MIF plays a key role in the development of metastatic disease by regulating angiogenesis and immunity, as well as by activating, through its binding to the CD74 receptor, the MAPK and the PI3K/AKT pathways, which are the most important signaling pathways in the development of melanoma.